Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Taragarestrant (D-0502) is an orally active estrogen receptor degrader with anticancer activity. taragarestrant exhibits anti-proliferative effects on estrogen receptor positive breast cancer cell lines. taragarestrant can be used in cancer research.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 2,140.00 | |
50 mg | 8-10 weeks | $ 2,785.00 | |
100 mg | 8-10 weeks | $ 3,520.00 |
Description | Taragarestrant (D-0502) is an orally active estrogen receptor degrader with anticancer activity. taragarestrant exhibits anti-proliferative effects on estrogen receptor positive breast cancer cell lines. taragarestrant can be used in cancer research. |
Molecular Weight | 475.38 |
Formula | C25H25Cl2FN2O2 |
CAS No. | 2118899-51-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Taragarestrant 2118899-51-5 inhibitor inhibit